Women with polycystic ovary syndrome (PCOS) appear to have an increased frequency of sleep problems. The aim of this study was to explore the effect of auricular point acupressure (APA) pressure on sleep quality in women with PCOS.
Polycystic ovary syndrome (PCOS) is a prevalent disorder affecting 5-18% of reproductive-age women. In recent years, women with PCOS appear to have an increased frequency of sleep problems, and the prevalence of poor sleep in PCOS is high at 31%. The aim of this study was to explore the effect of auricular point acupressure (APA) pressure on sleep quality in women with PCOS. We verified the effect of APA pressure on sleep quality, quality of life, anxiety level, sex hormone indexes, and biochemical indexes in two groups after the intervention. So as to provide a sleep management strategy in PCOS women for future clinical practice guidelines.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Enrollment
88
Auricular point acupressure (APA) is a method derived from Traditional Chinese Medicine. PCOS women in the APA group began to apply pressure on the first day of enrollment. Patients were instructed to press each acupuncture point 3 times a day for 30 times. The PCOS woman is then trained to go to the outpatient clinic every 5-7 days to change the auricular acupressure sticker. The intervention period was 4 weeks.
Department of Endocrinology and Diabetes, the First Affiliated Hospital of Xiamen University, School of medicine, Xiamen university, Xiamen, China
Xiamen, Fujian, China
Pittsburgh Sleep Quality Index (PSQI)
The PSQI is a cornerstone tool for the assessment of sleep quality
Time frame: Baseline and 30 days
Modified Polycystic Ovary Syndrome Health Related Quality of Life Questionnaire (MPCOSQ)
Time frame: Baseline and 30 days
Self-Rating Anxiety Scale (SAS)
The cutoff value for anxiety assessment of Self-Rating Anxiety Scale (SAS) is 50 oints, and the higher the score, the more obvious the anxiety tendency. Below 49 is normal; 50-59 is mild; 60-69 is moderate; A score of 69 or above is considered severe.
Time frame: Baseline and 30 days
Testosterone (T) level(ng/mL）
Time frame: Baseline and 30 days
Progesterone (P) level(ng/mL）
Time frame: Baseline and 30 days
fasting serum insulin (pmol/L)
Time frame: Baseline and 30 days
fasting blood-glucose(mmol/L)
Time frame: Baseline and 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.